MC
EXAS

Mayo Clinic’s Exact Sciences EXAS Stock Holding History

Mayo Clinic’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,167
Closed -$297K – 11
2023
Q2 		$297K Sell
3,167
-1,984
-39% -$155K 0.31% 6
2023
Q1 		$349K Buy
5,151
+1,496
+41% +$96.2K 0.29% 4
2022
Q4 		$181K Buy
+3,655
New +$149K 0.1% 10
2021
Q1 		– Sell
-1,304
Closed -$173K – 9
2020
Q4 		$173K Sell
1,304
-1,985
-60% -$240K 0.21% 9
2020
Q3 		$3.35M Buy
+3,289
New +$284K 4.52% 6
2020
Q2 		– Sell
-3,795
Closed -$220K – 10
2020
Q1 		$220K Hold
3,795
– – 0.56% 6
2019
Q4 		$351K Buy
+3,795
New +$334K 0.4% 6

Other funds holding EXAS

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Mayo Clinic's EXAS Position: Q3 2023 in Review

Mayo Clinic sold out of Exact Sciences (EXAS) in Q3 2023, closing a stake of 3,167 shares — an estimated $297K sold.

Mayo Clinic first reported a position in EXAS in Q4 2019 and held it in 7 quarters. The position peaked at $3.35M in Q3 2020. 624 funds tracked by Wall St. Rank hold EXAS as of Q3 2023.

  • Mayo Clinic reported no remaining Exact Sciences position as of Q3 2023 after selling out during the quarter.
  • Mayo Clinic sold 3,167 Exact Sciences shares in Q3 2023, an estimated $297K.
  • Mayo Clinic first reported a position in Exact Sciences in Q4 2019 and held it in 7 quarters.
  • Mayo Clinic's Exact Sciences position peaked at $3.35M in Q3 2020.
  • 624 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2023.

Based on Mayo Clinic's 13F filing for Q3 2023, filed 14 Nov 2023.